1 Both descriptive and inferential
analyses were done with 95% confidence intervals (CIs) at a p
2 Population genomic
analyses were done with a hierarchical gene-by-gene approach.
3 Meta-
analyses were done with a random effects model.
4 Analyses were done with all eligible patients who started pro
5 Efficacy and safety
analyses were done with all randomly assigned patients who re
6 All
analyses were done with and without inclusion of the SHOCK tr
7 Large-restriction-fragment (LRF) pattern
analyses were done with AseI.
8 Univariate and multivariate
analyses were done with Cox proportional hazard regression.
9 Analyses were done with Cox regression analyses adjusted for
10 Analyses were done with Cox regression analyses and adjusted
11 nd lack of cooperation were used as exclusion criteria, and
analyses were done with data from 4869 eyes.
12 Multiple logistic regression
analyses were done with every primary outcome as the dependen
13 Additional
analyses were done with finer categorisation of heart rate, a
14 whom a PICC was not inserted from safety analyses, as these
analyses were done with groups defined by the PICC used.
15 Intention-to-treat
analyses were done with linear regression.
16 Sensitivity
analyses were done with regard to how the value of a statisti
17 Kinetic
analyses were done with software using a 1-tissue-compartment
18 All further
analyses were done with the BCI-L model.
19 Comparative
analyses were done with the deletions and the parental wild t
20 All
analyses were done with the entire sample of 13-24-year-olds
21 Meta-
analyses were done with the Mantel-Haenszel method with a ran
22 All
analyses were done with the modified intention-to-treat popul
23 Mutational
analyses were done with VZV cosmids generated from parent Oka